Colorectal cancer metastatic – Basic Information

Go back

Metastatic colorectal cancer represents an advanced stage of the disease where cancer cells that began in the colon or rectum have traveled to distant parts of the body, creating new tumors in organs far from where the cancer first appeared.

Understanding Metastatic Colorectal Cancer

When doctors talk about metastatic colorectal cancer, they are describing a situation where cancer that started in the large intestine has spread beyond its original location. This condition is also known as stage 4 colorectal cancer or advanced colorectal cancer. The process happens when cancer cells break away from the original tumor and travel through the blood or lymph system (a network of vessels and nodes that help fight infection) to reach distant parts of the body, where they begin growing into new tumors.[1]

The most common places where colorectal cancer spreads include the liver, lungs, the lining of the abdominal cavity (the space inside the belly that holds organs) known as the peritoneum, and distant lymph nodes. The liver is particularly vulnerable because blood from the intestines flows directly to it, making it the most frequent site of spread.[1]

Approximately 23 percent of people are already diagnosed with metastatic disease at the time they first learn they have colorectal cancer. Additionally, up to half of all people diagnosed with colon cancer will eventually develop metastases in other parts of their body.[1][7]

Epidemiology and Survival Rates

Colorectal cancer stands as the third most common cause of cancer worldwide and ranks as the second most common cause of cancer-related death globally. Despite advances in treatment and improving survival rates for many cancer types, metastatic colorectal cancer continues to present significant challenges. The five-year survival rate for people with metastatic colorectal cancer is approximately 14 percent, making it a particularly serious diagnosis.[2]

This relatively low survival rate reflects the difficulty in treating cancer once it has spread throughout the body. When cancer remains localized and can be removed surgically before it spreads, the chances of long-term survival are much higher. However, once the disease becomes metastatic, treatment becomes more complex and focused on managing the disease rather than curing it in most cases.[3]

How Cancer Spreads: The Metastatic Process

Understanding how colorectal cancer spreads helps explain why early detection is so important. Cancer begins as abnormal cells growing in one location of the colon or rectum. As the tumor grows larger and cancer cells accumulate more genetic changes or mutations (alterations in the cell’s DNA), some cells acquire the ability to break away from the primary tumor.[5]

Research has revealed surprising findings about when this spread occurs. For many years, doctors assumed that metastasis typically happens later in the disease process, after the original tumor had grown quite large. However, recent studies using advanced genetic analysis have shown that colorectal cancer can actually spread very early in the disease, possibly years before the cancer is diagnosed through standard screening tests. This early spread may happen when the original tumor is still quite small and hasn’t yet caused any symptoms.[5]

⚠️ Important
Sometimes cancer cells are too small to be detected by current medical tests. These microscopic cells may continue to grow silently in the body and show up months or even years after treatment as metastatic cancer. This is why doctors recommend regular follow-up appointments and monitoring even after successful treatment of the original tumor.

Colorectal cancer typically spreads in a predictable pattern. The cancer often moves first to nearby lymph nodes in the area around the intestine. From there, it can travel to the liver, lungs, or other distant organs. In some cases, cancer can spread to the tissue lining the wall of the abdomen, or to more unusual sites like the brain or bones.[3][4]

Stages of Metastatic Colorectal Cancer

Stage 4 colorectal cancer is divided into three subcategories that help doctors understand the extent of spread and plan treatment. Stage IVA means the cancer has spread to one distant area or organ that is not near the colon or rectum, such as a single spot in the liver or lung, or to a distant lymph node. Stage IVB indicates that cancer has spread to more than one distant area or organ. Stage IVC describes cancer that has spread to the peritoneum and may also have spread to other distant areas or organs.[4]

This staging system helps medical teams communicate clearly about each patient’s situation and guides treatment decisions. The number and location of metastases significantly influence what treatments might be most appropriate and what outcomes might be expected.[4]

Symptoms of Metastatic Colorectal Cancer

One of the challenges with metastatic colorectal cancer is that it doesn’t always cause symptoms, even when it has progressed significantly. Some people feel relatively well despite having advanced disease, while others experience various symptoms depending on where the cancer has spread.[1]

General symptoms that may occur include feeling full soon after starting to eat, noticing a lump in the belly button area, or experiencing changes in bowel habits such as more frequent diarrhea, constipation, or changes in the shape of stools. Rectal bleeding or visible blood in the stool can occur, though this may not be obvious to the naked eye. Some people develop iron deficiency anemia (low red blood cell counts caused by insufficient iron), which can lead to tiredness, weakness, and changes in skin color.[1]

Ongoing discomfort in the belly area is common, including cramps, gas, bloating, or pain. Some people feel that their bowel doesn’t empty completely during a bowel movement, even if they go to the bathroom frequently. Pain in the back, buttocks, or legs can also occur.[1][3]

When cancer has spread to specific organs, additional symptoms may develop. If metastases are in the liver, a person might experience pain in the upper right part of the abdomen, unexplained weight loss, yellowing of the skin and eyes called jaundice (caused by bile buildup when the liver isn’t functioning properly), or swelling in the belly. Spread to the lungs can cause shortness of breath, persistent cough, or chest pain. Brain metastases might cause headaches, seizures, dizziness, confusion, or vision problems.[1][3]

Causes and Risk Factors

Doctors don’t know the exact cause of why some colorectal cancers become metastatic while others remain localized. The development of metastatic disease appears to depend on complex interactions between genetic changes within cancer cells and various factors in the body’s environment. Research has shown that certain genetic mutations present in the primary tumor can make cancer cells more likely to spread to distant sites.[3]

What scientists have learned is that cancer cells capable of metastasizing often acquire these abilities quite early. By examining the genetic makeup of both primary tumors and metastatic tumors from the same patients, researchers found that in about 80 percent of cases, the driver mutations (key genetic changes that help cancer grow and spread) found in metastatic tumors were already present in the original tumor. This suggests that cells with the potential to spread break away from the primary tumor early in its development.[5]

Diagnosis of Metastatic Colorectal Cancer

Diagnosing metastatic colorectal cancer involves multiple types of tests and examinations. Doctors typically start with a physical exam and then use various imaging tests to look for areas of cancer spread throughout the body. A colonoscopy (a procedure where a flexible tube with a camera examines the inside of the colon) allows doctors to see if cancer has returned to the intestine itself.[3]

Blood tests play an important role in diagnosis and monitoring. One key blood test measures carcinoembryonic antigen or CEA, a protein made by some colon cancer cells. Elevated CEA levels can indicate the presence or progression of colon cancer, particularly in advanced stages. However, this test isn’t perfect, as not all colorectal cancers produce CEA, and some non-cancerous conditions can also raise CEA levels.[8]

Imaging tests form the backbone of diagnosis for metastatic disease. CT scans (computed tomography, which uses X-rays and computers to create detailed cross-sectional images) and MRI scans (magnetic resonance imaging, which uses magnets and radio waves) can reveal whether cancer has spread to organs in the chest, belly, or pelvis. A PET scan (positron emission tomography, which uses radioactive tracers to highlight active cancer cells) may help doctors determine if surgery might be an option for treating cancer that has spread outside the colon.[8]

When imaging tests show suspicious masses in organs like the liver or lung, doctors usually perform a biopsy (removing a small tissue sample for laboratory examination) to confirm whether these are actually cancer and not something else. Brain CT scans or MRIs help investigate symptoms like confusion, numbness, or severe headaches that might suggest brain involvement. A bone scan can detect whether cancer cells have spread to the bones.[3]

An important part of the diagnostic process involves molecular and genetic testing of the cancer cells themselves. These laboratory tests examine the specific gene changes present in the cancer, which helps doctors understand how aggressive it might be and, critically, which treatments are most likely to work. Some medications only work for cancers with specific genetic features, making this testing essential for treatment planning.[8]

Treatment Approaches

Treatment for metastatic colorectal cancer is complex and highly individualized. The specific approach depends on many factors including where the cancer has spread, how many metastatic sites exist, the person’s overall health, and what matters most to the individual patient. The main goal of treatment is typically to keep the cancer under control, relieve symptoms, and maintain quality of life for as long as possible.[3]

While metastatic colorectal cancer generally cannot be cured, treatment can sometimes control the disease for extended periods. For a small number of people whose cancer has spread to just one other body part and where surgeons can completely remove both the original tumor and the metastases, a cure might actually be possible. This scenario is most common when cancer has spread to a limited area of the liver that can be surgically removed.[16]

Chemotherapy (drugs that kill rapidly dividing cancer cells) remains a cornerstone of treatment for metastatic disease. These medications travel throughout the bloodstream, reaching cancer cells wherever they may be hiding in the body. Surgery may still play a role in selected cases, particularly when metastases are limited to one or a few spots that can be safely removed.[1]

Targeted therapy represents a more precise approach that uses drugs designed to attack specific features of cancer cells. These medications work differently from traditional chemotherapy by zeroing in on particular molecular targets that help cancer grow and survive. Immunotherapy harnesses the body’s own immune system to recognize and attack cancer cells, though this approach works better for some types of colorectal cancer than others, depending on the cancer’s genetic characteristics.[1][3]

For people with metastases limited to the liver, additional specialized treatments may be available. These include thermal ablation (using heat to destroy tumors), embolization (blocking blood supply to tumors), or specialized techniques that deliver chemotherapy directly to the liver. Some advanced centers offer hepatic artery infusion, which delivers concentrated chemotherapy directly into the liver’s blood supply, or procedures like HIPEC (hyperthermic intraperitoneal chemoperfusion), which uses heated chemotherapy to kill cancer cells in the abdominal cavity.[3][11]

Radiation therapy (using high-energy beams to kill cancer cells) may be used to treat specific areas of metastatic disease, particularly to relieve pain or other symptoms. Advanced radiation techniques can precisely target tumors while sparing surrounding healthy tissue.[1]

Clinical trials offer access to cutting-edge treatments that are still being studied. These research studies test new drugs, new combinations of existing drugs, or entirely new approaches to treating cancer. For some people with metastatic disease, participation in a clinical trial may provide access to promising treatments not yet available through standard care.[3]

⚠️ Important
Treatment decisions for metastatic colorectal cancer should involve open discussions between patients and their medical team about treatment goals, potential benefits and side effects, and personal preferences. What works best for one person may not be ideal for another. Some people prioritize extending life as long as possible, while others focus more heavily on maintaining quality of life and managing symptoms with minimal side effects.

Pathophysiology: What Happens in the Body

At the cellular level, metastatic colorectal cancer involves profound changes in how cancer cells behave compared to normal colon cells. Cancer cells accumulate multiple genetic mutations that allow them to ignore the normal signals that keep cell growth in check. These mutations enable cancer cells to divide uncontrollably, avoid the programmed cell death that would normally eliminate damaged cells, and develop the ability to invade through tissues and survive in foreign environments.[2]

A key process in metastasis involves something called epithelial-mesenchymal transition, where cancer cells change their characteristics to become more mobile and invasive. Cells that normally stay anchored in place as part of the intestinal lining transform to become more like cells that can move through the body. This transformation allows them to break through the barriers that would normally contain them.[2]

The tumor microenvironment (the area immediately surrounding the tumor, including blood vessels, immune cells, and supporting tissue) plays a crucial role in metastasis. Cancer cells manipulate this environment to support their growth, triggering the formation of new blood vessels that supply nutrients and oxygen, and suppressing immune responses that would normally attack abnormal cells. Some cancer cells even enter a dormant state after spreading to distant organs, lying quiet for months or years before beginning to grow into detectable metastases.[2]

When colorectal cancer spreads to organs like the liver or lungs, the metastatic tumors can disrupt normal organ function. Liver metastases can interfere with the liver’s vital roles in filtering blood, producing proteins needed for blood clotting, and processing nutrients. Lung metastases can impair breathing by taking up space where gas exchange normally occurs. The cumulative burden of disease throughout the body, combined with the body’s response to cancer, contributes to symptoms like fatigue, weight loss, and declining function.[1]

Living with Metastatic Colorectal Cancer

A diagnosis of metastatic colorectal cancer brings significant emotional, physical, and practical challenges. Learning that the cancer cannot be cured is distressing and often comes as a shock. It’s completely normal to feel uncertain, anxious, or overwhelmed, and to find yourself unable to think about anything else for a while. These reactions are a natural part of processing difficult news.[16]

Many people find that learning more about their diagnosis and treatment options helps them feel more in control of their situation. Understanding what’s happening in your body, what treatments might help, and what side effects to expect can make it easier to cope and to participate actively in decisions about your care. At the same time, it’s important to recognize that not everyone wants detailed information, and that’s okay too.[16]

Physical changes are likely as the disease and its treatment progress. These might include having a colostomy (a surgical opening in the abdomen where the intestine is brought to the skin surface, allowing waste to collect in an external bag), dealing with ongoing bowel problems like diarrhea, or managing side effects from treatments. Specialized nurses can provide crucial support in learning to manage these changes and maintain quality of life.[16]

Communication with family and friends can be complicated. While loved ones can provide valuable support, some may find it difficult to discuss what’s happening because they’re worried about emotional reactions or about burdening you. You can help by letting people know that you’re open to discussing your situation and how you feel. However, you might also find it helpful to talk with someone outside your immediate circle, such as a counselor or support group, where you can express feelings more freely.[16]

Planning and setting priorities can help you feel more in control. While some future plans may need to be adjusted, this can also be an opportunity to focus on what truly matters to you. Your medical team can often work with you to schedule treatments around important events or activities, helping you make the most of your time.[16]

Supportive care and symptom management are essential components of treatment. This includes not just medications to control pain or other physical symptoms, but also support for emotional well-being, help with practical matters like finances and transportation, and assistance for family members and caregivers. The goal is to help you maintain the best possible quality of life throughout your journey with metastatic colorectal cancer.[7]

Ongoing Clinical Trials on Colorectal cancer metastatic

  • Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study on the Safety and Effectiveness of Trifluridine/Tipiracil, Capecitabine, and Bevacizumab for Patients with Metastatic Colorectal Cancer Unfit for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Italy
  • Study on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study Comparing Avelumab and Standard Chemotherapy for Patients with Metastatic Colorectal Cancer with Microsatellite Instability

    Not recruiting

    2 1 1 1
    France
  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    France Germany Italy Spain
  • Study Comparing Sacituzumab Govitecan with Standard Treatment for Patients with Metastatic Colorectal Cancer

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Germany
  • Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

    Not recruiting

    2 1 1 1
    Czechia Slovakia
  • Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal Spain
  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Italy +4
  • Study of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer

    Not recruiting

    2 1 1 1
    Germany

References

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/symptoms-causes/syc-20584697

https://pmc.ncbi.nlm.nih.gov/articles/PMC10365888/

https://www.columbiadoctors.org/health-library/condition/colorectal-cancer-metastatic-or-recurrent/

https://colorectalcancer.org/basics/stages-colorectal-cancer/stage-iv

https://www.cancer.gov/news-events/cancer-currents-blog/2019/early-metastasis-colorectal-cancer

https://www.peacehealth.org/medical-topics/id/tv7567

https://www.fruzaqla.com/metastatic-colorectal-cancer

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/diagnosis-treatment/drc-20584817

https://www.mskcc.org/cancer-care/types/colon/treatment/metastases

https://www.cancer.org/cancer/types/colon-rectal-cancer/treating/by-stage-colon.html

https://www.uchicagomedicine.org/cancer/types-treatments/colorectal-cancer/metastatic-colorectal-cancer-treatment

https://pubmed.ncbi.nlm.nih.gov/36252154/

https://www.mdanderson.org/cancer-types/colon-cancer/colon-cancer-treatment.html

https://www.cancer.org/cancer/types/colon-rectal-cancer/after-treatment/living.html

https://www.mayoclinic.org/diseases-conditions/stage-4-colon-cancer/diagnosis-treatment/drc-20584817

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/metastatic/coping-support

https://colorectalcancer.org/basics/stages-colorectal-cancer/stage-iv

https://www.fruzaqla.com/metastatic-colorectal-cancer

https://www.mdanderson.org/cancerwise/stage-iv-colorectal-cancer-survivor—md-anderson-gave-me-a-second-chance.h00-159624168.html

https://www.bowelcanceruk.org.uk/news-and-blogs/this-is-bowel-cancer-blog/what-i-wish-i-had-been-told-when-i-was-diagnosed-at-stage-4/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What’s the difference between metastatic and recurrent colorectal cancer?

Metastatic cancer means the cancer has spread from the colon or rectum to other parts of the body, either when first diagnosed or after treatment. Recurrent cancer means the cancer has come back months or years after treatment, and it may or may not have spread to distant organs. Cancer can be both metastatic and recurrent if it returns after treatment and has spread to distant sites.

Can metastatic colorectal cancer ever be cured?

While metastatic colorectal cancer generally cannot be cured, there are exceptions. For a small number of people whose cancer has spread to just one other area (like a limited portion of the liver) and where surgeons can completely remove both the original tumor and the metastases, a cure might be possible. Treatment can also keep the cancer under control for extended periods in some patients.

Why does colorectal cancer most often spread to the liver?

The liver is the most common site for colorectal cancer spread because blood from the intestines flows directly to the liver through a large blood vessel called the portal vein. This direct connection provides an easy path for cancer cells that break away from tumors in the colon or rectum to reach the liver and begin growing there.

How often do I need to be monitored after treatment for colorectal cancer?

Monitoring schedules vary based on individual circumstances, but doctors typically recommend regular follow-up appointments with physical exams, blood tests (including CEA levels), and imaging scans. These follow-ups continue for several years because cancer can recur or spread even after successful initial treatment. Your doctor will create a monitoring schedule tailored to your specific situation.

What is biomarker testing and why is it important for metastatic colorectal cancer?

Biomarker testing examines the specific genetic and molecular characteristics of your cancer cells. This testing is crucial because it helps doctors understand which treatments are most likely to work for your particular cancer. Some medications only work for cancers with specific genetic features, so this testing guides treatment selection and helps personalize your care plan.

🎯 Key takeaways

  • Metastatic colorectal cancer affects approximately 23% of people at initial diagnosis, with up to half of all colorectal cancer patients eventually developing metastases.
  • Cancer cells can break away and travel to distant organs surprisingly early in the disease, sometimes years before the primary tumor is large enough to detect.
  • The liver, lungs, peritoneum, and distant lymph nodes are the most common destinations for spreading colorectal cancer cells.
  • The five-year survival rate for metastatic colorectal cancer is about 14%, though new treatments are improving outcomes for many patients.
  • Treatment involves multiple approaches including chemotherapy, surgery, targeted therapy, immunotherapy, and radiation, tailored to each person’s specific situation.
  • Molecular and genetic testing of cancer cells is essential for identifying which treatments are most likely to be effective for each individual.
  • Metastatic disease doesn’t always cause symptoms initially, and symptoms when present depend largely on where the cancer has spread.
  • While cure is possible for a small number of patients with limited metastases, the primary goal for most is controlling the disease and maintaining quality of life.

Connected medications: